AI-generated summary
The authors studied 78 patients with moderate mixed-type bronchial asthma and chronic rhinosinusitis, comparing infrared laser applied to the tympanic membrane and sinus area with supravenous laser and medication alone. They report the greatest improvement in the group receiving infrared laser plus medication, with the least effect in the medication-only group. The study's design limits and the reported outcome measures are not described in detail in the abstract.
- Participants
- 78
- Who or what was studied
- Patients with moderate mixed-type bronchial asthma and concomitant chronic rhinosinusitis
- Limits stated in the abstract
- The abstract gives few methodological details, such as group sizes, randomization, blinding, or statistical testing, so the strength of the reported benefit cannot be judged from it.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.